학술논문

A TLR7 agonist strengthens T and NK cell function during BRAF-targeted therapy in a preclinical melanoma model
Document Type
Article
Source
In: International Journal of Cancer. (International Journal of Cancer, 1 March 2020, 146(5):1409-1420)
Subject
Language
English
ISSN
10970215
00207136